drugset / Trial / NCT03978598

Breastfeeding Etonogestrel Implant Study

NCT03978598

RandomizedParallel-groupOpen-labelTreatment

Summary

The investigators are studying the effect of placing the etonogestrel implant (Nexplanon) in the first 24 hours after birth on breastfeeding. Women who wish to have an etonogestrel implant placed after their birth, wish to breastfeed, and are willing to participate in the study will be randomly assigned to either get the implant placed in the first 24 hours after delivery of the baby and placenta or 4-6 weeks later. The investigators do not believe there will be a difference in breastfeeding 8 weeks after delivery or time to lactogenesis between those who get the implant placed early or later.

Timeline

Start
2019-06-03
Primary completion
2024-06-04
Completion
2024-09-19

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Etonogestrel Unknown Other

Indications

No indication recorded.